Literature DB >> 1587736

Sublethal damage repair in squamous cell carcinoma cell lines.

K Pekkola-Heino1, J Kulmala, R Grenman.   

Abstract

Squamous cell carcinoma (SCC) cell lines recently established from head and neck tumors were studied for their capability of repairing sublethal radiation induced damage (SLDR). Total doses of 1.25, 2.50, 5.00, and 7.50 Gy were used either as a single dose or split in two equal fractions with a 24 h interval. Cell survival was determined using a 96-well plate clonogenic assay based on limiting dilution. Survival data was fitted by linear quadratic model, and the area under the survival curve (AUC) was obtained with numerical integration. The amount of SLDR was expressed as AUC-ratio comparing survivals from split dose vs single dose experiments. SLDR capacity was observed to vary markedly between individual cell lines (AUC-ratios 1.0-1.5). The relatively radiation-sensitive cell lines had a tendency toward higher SLDR proficiency (correlation coefficient 0.85). The differences in repair capacity could not be explained by the differences in doubling times of the cell lines. The inverse relationship between SLDR capacity and inherent radiosensitivity could explain the poor radiocurability of the sensitive donor tumors. Two of the most resistant cell lines were found SLDR deficient. This is a novel finding, since SLDR has been previously reported in all studied cells.

Entities:  

Mesh:

Year:  1992        PMID: 1587736     DOI: 10.1002/hed.2880140306

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.

Authors:  V Rantanen; S Grénman; J Kulmala; K Alanen; T Lakkala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.

Authors:  Michelle Lenarduzzi; Angela B Y Hui; Shijun Yue; Emma Ito; Wei Shi; Justin Williams; Jeff Bruce; Noriko Sakemura-Nakatsugawa; Wei Xu; Aaron Schimmer; Fei-Fei Liu
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

5.  MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.

Authors:  Michelle Lenarduzzi; Angela B Y Hui; Nehad M Alajez; Wei Shi; Justin Williams; Shijun Yue; Brian O'Sullivan; Fei-Fei Liu
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

6.  Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

7.  Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.

Authors:  Susana Llanos; Juana M García-Pedrero; Lucia Morgado-Palacin; Juan P Rodrigo; Manuel Serrano
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.